EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

Press Release
 
Eltek Ltd. Reports 2023 Second Quarter Financial Results
 
Petach Tikva, Israel (August 21, 2023) Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), today announced its financial results for the quarter ended June 30, 2023.
 
Second Quarter 2023 Highlights
 

Revenues were $11.0 million, 21% up over Q2 2022
 

Operating profit was $1.4 million, 300% up over Q2 2022
 

Profit before tax was $1.6 million (2022 Q2 - $1.0 million)
 

Net income was $1.3 million or $0.22 per fully diluted share, 74% up over Q2 2022
 

As of June 30, 2023 cash and cash equivalents amounted $8.3 million, after full repayment of bank loans.
 
"We are proud to announce our strong second quarter results for 2023, with a growth of 21% in sales compared to the same quarter last year. The second quarter is characterized by a relatively low number of working days due to holidays. Despite this, we managed to achieve $11 million in sales," said Eli Yaffe, CEO of Eltek.

"Throughout the quarter, we continued to experience the demand for our high-end, high-reliability products. In light of the continued demand for our products, we continue our efforts to recruit employees and to procure and install new machines that will enable us to increase manufacturing capacity," continued Mr. Yaffe.

"Earlier this month, we were informed by the Ministry of Environmental Protection that it rejected our claim to reduce the clean air penalty imposed on us. Therefore, we have provided a full allowance for this penalty in our Q2 interim financial statements and recorded a one-time expense in the amount of $0.35 million," concluded Mr. Yaffe.



Second Quarter 2023 GAAP Financial Results
 
Revenues for the second quarter of 2023 were $11.0 million, compared to $9.1 million in the second quarter of 2022;
 
Gross profit for the second quarter of 2023 was $3.0 million (27% of revenues) compared to $1.7 million (18% of revenues) in the second quarter of 2022;
 
Operating profit for the second quarter of 2023 was $1.4 million compared to operating profit of $0.3 million in the second quarter of 2022;
 
Profit before income tax for the second quarter of 2023 was $1.6 million compared to $1.0 million in the second quarter of 2022;
 
Net income for the second quarter of 2023 was $1.3 million or $0.22 per fully diluted share compared to net income of $0.8 million or $0.13 per fully diluted share in the second quarter of 2022;
 
Second Quarter 2023 Non-GAAP Financial Results
 
EBITDA for the second quarter of 2023 was $1.7 million (15.3% of revenues) compared to EBITDA of $0.8 million (8.7% of revenues) in the second quarter of 2022;
 
First Six Months 2023 GAAP Financial Results
 
Revenues for the first six months of 2023 were $22.5 million compared to $18.8 million in the first six months of 2022;
 
Gross profit for the first six months of 2023 was $6.0 million (26% of revenues) compared to $3.6 million (19% of revenues) in the first six months of 2022;
 
Operating profit for the first six months of 2023 was $3.0 million compared to operating profit of $1.0 million in the first six months of 2022;
 
Financial income for the first six months of 2023 was $0.4 million compared to financial income of $0.7 million in the first six months of 2022. Financial income primarily results from the erosion of the NIS against the US dollar.
 
Profit before income tax for the first six months of 2023 was $3.5 million compared to $1.7 million in the first six months of 2022;



 
Net profit for the first six months of 2023 was $2.9 million or $0.49 per fully diluted share compared to net profit of $1.4 million or $0.24 per fully diluted share in the first six months of 2022;
 
First Six Months 2023 Non-GAAP Financial Results
 
EBITDA for the first six months of 2023 was a $3.6 million (16% of revenues) compared to EBITDA of $1.9 million (10% of revenues) in the first six months of 2022;
 
About our Non-GAAP Financial Information
 
The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the Company's results on a GAAP and non-GAAP basis is provided in a table below.
 
Conference Call
 
Today, Monday, August 21, 2023, at 8:30am Eastern Time (15:30pm Israel Time, 5:30am Pacific Time), Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer.
 
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
 
United States:
1-866-860-9642
Israel:  
03-918-0691
International: 
+972-3-918-0691

To Access a Replay of the Call
 
A replay of the call will be available for 30 days on the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the conference call is completed.


 
About Eltek
 
Eltek – ”Innovation Across the Board”, is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.
 
Eltek was founded in 1970. The Company’s headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.
 
For more information, visit Eltek's web site at www.nisteceltek.com

Forward Looking Statement
 
Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company’s Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.
 
Investor Contact
 
Ron Freund
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023

(Tables follow)


Eltek Ltd.
Consolidated Statements of Income
(Unaudited, in thousands US$, except per share data)

   
Three months ended
   
Six months ended
 
   
June 30,
   
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
                         
Revenues
   
11,043
     
9,089
     
22,513
     
18,844
 
Costs of revenues
   
(8,091
)
   
(7,411
)
   
(16,546
)
   
(15,205
)
                                 
Gross profit
   
2,952
     
1,678
     
5,967
     
3,639
 
                                 
Selling, general and administrative expenses
   
(1,543
)
   
(1,306
)
   
(2,960
)
   
(2,598
)
R&D expenses, net
   
(15
)
   
(26
)
   
(24
)
   
(44
)
                                 
Operating profit
   
1,394
     
346
     
2,983
     
997
 
                                 
Financial income (expenses), net
   
190
     
611
     
477
     
732
 
                                 
Income before income tax
   
1,584
     
957
     
3,460
     
1,729
 
                                 
Taxes on income
   
271
     
204
     
585
     
344
 
                                 
Net income
   
1,313
     
753
     
2,875
     
1,385
 
                                 
Earnings per share:
                               
Basic and diluted net profit per ordinary share
   
0.22
     
0.13
     
0.49
     
0.24
 
                                 
Weighted average number of ordinary shares used to compute
                         
basic net profit per ordinary share (in thousands)
   
5,908
     
5,850
     
5,879
     
5,846
 
Weighted average number of ordinary shares used to compute
                         
diluted net profit per ordinary share (in thousands)
   
5,943
     
5,850
     
5,897
     
5,846
 


Eltek Ltd.
Consolidated Balance Sheets
(Unaudited, in thousands US$)

   
June 30,
   
December 31,
 
   
2023
   
2022
 
             
Assets
           
             
Current assets:
           
Cash and cash equivalents
   
8,330
     
7,366
 
Receivables:   Trade, net of provision for doubtful accounts
   
11,383
     
10,116
 
                       Other
   
733
     
282
 
Inventories
   
5,688
     
5,130
 
Prepaid expenses
   
326
     
504
 
                 
Total current assets
   
26,460
     
23,398
 
                 
Long term assets:
               
Restricted deposits
   
-
     
202
 
Severance pay fund
   
56
     
59
 
Deferred tax assets and long term tax receivables, net
   
1,808
     
2,496
 
Operating lease right of use assets
   
6,742
     
7,156
 
Total long term assets
   
8,606
     
9,913
 
                 
Fixed assets, less accumulated depreciation
   
6,399
     
7,674
 
                 
Total Assets
   
41,465
     
40,985
 
                 
Liabilities and Shareholder's equity
               
                 
Current liabilities:
               
Short-term credit and current maturities of long-term debts
   
-
     
702
 
Accounts payable: Trade
   
4,690
     
4,793
 
                              Other
   
6,352
     
4,133
 
Short-term operating lease liabilities
   
788
     
846
 
                 
Total current liabilities
   
11,830
     
10,474
 
                 
Long-term liabilities:
               
Long term debt, excluding current maturities
   
-
     
2,768
 
Employee severance benefits
   
288
     
280
 
Long-term operating lease liabilities
   
6,058
     
6,443
 
                 
Total long-term liabilities
   
6,346
     
9,491
 
                 
Shareholders' equity:
               
Ordinary shares of NIS 3.0 par value – Authorized: 10,000,000 shares at June 30, 2023 and December 31, 2022; Issued and outstanding: 5,907,715 shares at June 30, 2023 and 5,849,678 shares at December 31, 2022
   
5,353
     
5,305
 
Additional paid-in capital
   
23,113
     
22,862
 
Cumulative foreign currency translation adjustments
   
140
     
1,189
 
Capital reserve
   
1,681
     
1,537
 
Accumulated deficit
   
(6,998
)
   
(9,873
)
Total shareholders' equity
   
23,289
     
21,020
 
Total liabilities and shareholders' equity
   
41,465
     
40,985
 



Eltek Ltd.
Unaudited Non-GAAP EBITDA Reconciliations
(In thousands US$)

   
Three months ended
   
Six months ended
 
   
June 30,
   
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
                         
GAAP net Income
   
1,313
     
753
     
2,875
     
1,385
 
Add back items:
                               
                                 
Financial expenses (income), net
   
(190
)
   
(611
)
   
(477
)
   
(732
)
Income tax expenses
   
271
     
204
     
585
     
344
 
Depreciation and amortization
   
301
     
445
     
630
     
880
 
Non-GAAP EBITDA
   
1,695
     
791
     
3,613
     
1,877
 


Eltek Ltd.
Consolidated Statement of  Cash flow
(Unaudited, in thousands US$)

   
Three months ended
   
Six months ended
 
   
June 30,
   
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
                         
Cash flows from operating activities:
                       
                         
Net Income
   
1,313
     
753
     
2,875
     
1,385
 
Adjustments to reconcile net income to net cash flows
                         
provided by operating activities:
                               
Depreciation and amortization
   
301
     
445
     
630
     
880
 
Stock-based compensation
   
72
     
64
     
144
     
117
 
Decrease in deferred tax assets and long term tax receivable
   
260
     
194
     
566
     
335
 
     
633
     
703
     
1,340
     
1,332
 
                                 
Decrease (increase) in operating lease right-of-use assets
   
11
     
(8
)
   
(22
)
   
(4
)
Decrease (increase) in trade receivables
   
(1,896
)
   
(1,140
)
   
(1,784
)
   
(2,300
)
Decrease (increase) in other receivables and prepaid expenses
   
214
     
165
     
(311
)
   
83
 
Decrease (increase) in inventories
   
(496
)
   
(57
)
   
(809
)
   
(731
)
Increase (decrease) in trade payables
   
(307
)
   
301
     
105
     
786
 
Increase (decrease) in other liabilities and accrued expenses
   
629
     
(204
)
   
1,477
     
302
 
Increase (decrease)  in employee severance benefits, net
   
17
     
(2
)
   
22
     
-
 
     
(1,828
)
   
(945
)
   
(1,322
)
   
(1,864
)
                                 
Net cash provided by operating activities
   
118
     
511
     
2,893
     
853
 
                                 
Cash flows from investing activities:
                               
Purchase of fixed assets
   
(406
)
   
(326
)
   
(711
)
   
(615
)
Insurance Proceeds
   
2,000
     
-
     
2,000
     
-
 
Restricted deposits
   
192
     
(1
)
   
192
     
(1
)
Net cash provided by (used in) investing activities
   
1,786
     
(327
)
   
1,481
     
(616
)
                                 
Cash flows from financing activities:
                               
Exercise of options
   
299
     
-
     
299
     
25
 
Repayment of long-term loans from bank
   
(1,768
)
   
(144
)
   
(3,348
)
   
(258
)
Repayment of credit from fixed asset payables
   
-
     
(3
)
   
-
     
(7
)
Net cash provided by (used in) financing activities
   
(1,469
)
   
(147
)
   
(3,049
)
   
(240
)
                                 
Effect of translation adjustments
   
(164
)
   
(845
)
   
(361
)
   
(1,034
)
                                 
Net increase (decrease) in cash and cash equivalents
   
271
     
(808
)
   
964
     
(1,037
)
                                 
Cash and cash equivalents at the beginning of the period
   
8,059
     
9,054
     
7,366
     
9,283
 
                                 
Cash and cash equivalents at the end of the period
   
8,330
     
8,246
     
8,330
     
8,246